DK0775160T3 - Cycliske hexapeptidsomatostatin-analoger - Google Patents
Cycliske hexapeptidsomatostatin-analogerInfo
- Publication number
- DK0775160T3 DK0775160T3 DK95928109T DK95928109T DK0775160T3 DK 0775160 T3 DK0775160 T3 DK 0775160T3 DK 95928109 T DK95928109 T DK 95928109T DK 95928109 T DK95928109 T DK 95928109T DK 0775160 T3 DK0775160 T3 DK 0775160T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptides
- somatostatin analogues
- cyclic hexapeptide
- reagents
- hexapeptide somatostatin
- Prior art date
Links
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 2
- 125000004122 cyclic group Chemical group 0.000 title 1
- 229940075620 somatostatin analogue Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 239000003153 chemical reaction reagent Substances 0.000 abstract 3
- 230000003439 radiotherapeutic effect Effects 0.000 abstract 2
- 102000001189 Cyclic Peptides Human genes 0.000 abstract 1
- 108010069514 Cyclic Peptides Proteins 0.000 abstract 1
- 102000005157 Somatostatin Human genes 0.000 abstract 1
- 108010056088 Somatostatin Proteins 0.000 abstract 1
- 229960000553 somatostatin Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/282,980 US5932189A (en) | 1994-07-29 | 1994-07-29 | Cyclic peptide somatostatin analogs |
| PCT/US1995/009276 WO1996004308A1 (en) | 1994-07-29 | 1995-07-20 | Cyclic hexapeptide somatostatin analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0775160T3 true DK0775160T3 (da) | 2004-10-25 |
Family
ID=23083971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95928109T DK0775160T3 (da) | 1994-07-29 | 1995-07-20 | Cycliske hexapeptidsomatostatin-analoger |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5932189A (da) |
| EP (1) | EP0775160B1 (da) |
| JP (1) | JP3117218B2 (da) |
| KR (1) | KR100322161B1 (da) |
| CN (1) | CN1181096C (da) |
| AT (1) | ATE273997T1 (da) |
| AU (1) | AU702917B2 (da) |
| BR (1) | BR9508467A (da) |
| CA (1) | CA2195395C (da) |
| DE (1) | DE69533399T2 (da) |
| DK (1) | DK0775160T3 (da) |
| ES (1) | ES2224131T3 (da) |
| WO (1) | WO1996004308A1 (da) |
| ZA (1) | ZA956254B (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69426673T2 (de) * | 1993-06-23 | 2001-09-20 | Diatide Inc | Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung |
| US6083480A (en) * | 1997-05-01 | 2000-07-04 | Diatide, Inc. | Calcitonin receptor binding reagents |
| US6358491B1 (en) * | 1999-08-27 | 2002-03-19 | Berlex Laboratories, Inc. | Somatostatin analogs |
| US6579967B1 (en) | 1999-12-14 | 2003-06-17 | The Salk Institute For Biological Studies | Receptor-selective somatostatin analogs |
| GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
| IL141276A0 (en) * | 2001-02-05 | 2002-03-10 | Peptor Ltd | Backbone cyclized radiolabelled somatostatin analogs |
| US7019109B2 (en) * | 2001-03-16 | 2006-03-28 | The Salk Institute For Bilogical Studies | SSTR1-selective analogs |
| KR100738362B1 (ko) * | 2001-03-19 | 2007-07-12 | 재단법인서울대학교산학협력재단 | 신규한 디아민디티올 유도체 및 그의 방사성 레늄 또는방사성 테크네슘 착체； 그리고, 그의 방사성 레늄 착체와리피오돌을 포함하는 간암 치료용 조성물 및 그의 제조용키트 |
| US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
| DE10215336A1 (de) * | 2002-03-28 | 2003-10-23 | Schering Ag | N-Methyl-Homocysteine und ihre Verwendung sowie Verfahren zu ihrer Herstellung |
| IL150384A0 (en) * | 2002-06-24 | 2002-12-01 | Peptor Ltd | Radiolabelled somatostatin analogs backbone cyclized through metal complexation |
| AU2003259172A1 (en) * | 2002-07-24 | 2004-02-09 | The Salk Institute For Biological Studies | Receptor (sstr4)- selective somatostatin analogs |
| JP4667868B2 (ja) * | 2002-08-06 | 2011-04-13 | アプラーゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング | 結合分子 |
| GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
| US7507708B2 (en) * | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
| GB0408958D0 (en) * | 2004-04-22 | 2004-05-26 | Pharma Mar Sa | Convergent synthesis for kahalalide compounds |
| EP1717247A1 (en) * | 2005-04-28 | 2006-11-02 | Schering AG | Cyclic peptides binding to the somatostatin receptor |
| WO2006114324A1 (en) * | 2005-04-28 | 2006-11-02 | Schering Ag | Compounds comprising cyclized somatostatin receptor binding peptides |
| US20070025910A1 (en) | 2005-07-29 | 2007-02-01 | Norenberg Jeffrey P | Anticancer therapy |
| US20070231258A1 (en) * | 2006-03-31 | 2007-10-04 | Karyon Ctt Ltd. | Peptide conjugates |
| ES2351569B8 (es) * | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
| US9005575B2 (en) | 2009-06-12 | 2015-04-14 | Stc.Unm | Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235886A (en) * | 1979-10-31 | 1980-11-25 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US4310518A (en) * | 1979-10-31 | 1982-01-12 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| NZ195303A (en) * | 1979-10-31 | 1984-10-19 | Merck & Co Inc | Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions |
| US4366148A (en) * | 1981-06-02 | 1982-12-28 | Brigham And Women's Hospital | Use of somatostatin in the prevention and cure of vascular, membrane, or organ lesions |
| EP0113029B1 (en) * | 1982-12-06 | 1989-04-19 | Merck & Co. Inc. | Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them |
| US4485101A (en) * | 1983-10-11 | 1984-11-27 | Administrators Of The Tulane Educational Fund | Peptides |
| DE8427783U1 (de) * | 1984-09-21 | 1985-05-15 | Rheinmetall GmbH, 4000 Düsseldorf | Gefechtskopf |
| US4611054A (en) * | 1985-04-29 | 1986-09-09 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US4612366A (en) * | 1985-06-17 | 1986-09-16 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US4904642A (en) * | 1985-09-12 | 1990-02-27 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
| US4853371A (en) * | 1986-06-17 | 1989-08-01 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
| US4871717A (en) * | 1987-01-07 | 1989-10-03 | Administrators Of The Tulane Educational Fund | Peptides |
| US5073541A (en) * | 1987-11-18 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Treatment of small cell lung cancer with somatostatin analogs |
| MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
| CA2012115C (en) * | 1989-03-15 | 2001-07-03 | Biomeasure, Inc. | Iodinated somatostatins |
| ATE140237T1 (de) * | 1989-12-08 | 1996-07-15 | Univ Tulane | Oktapeptidanaloge von somatostatin mit threonin in position 6 |
| DE69110519T2 (de) * | 1990-04-06 | 1995-11-30 | Univ Tulane | Somatostatinanaloge. |
| US5382654A (en) * | 1992-02-05 | 1995-01-17 | Mallinckrodt Medical, Inc. | Radiolabelled peptide compounds |
| ATE181240T1 (de) * | 1991-02-08 | 1999-07-15 | Biomeasure Inc | Verwendung von somatostatinanalogen zur behandlung von melanomen |
| US5620675A (en) * | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
| US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
| US5462926A (en) * | 1992-07-27 | 1995-10-31 | Biomeasure, Inc. | Neuromedin B receptor antagonists which demonstrate selectivity |
| DE69426673T2 (de) * | 1993-06-23 | 2001-09-20 | Diatide Inc | Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung |
| US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
| US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
-
1994
- 1994-07-29 US US08/282,980 patent/US5932189A/en not_active Expired - Fee Related
-
1995
- 1995-07-20 WO PCT/US1995/009276 patent/WO1996004308A1/en active IP Right Grant
- 1995-07-20 ES ES95928109T patent/ES2224131T3/es not_active Expired - Lifetime
- 1995-07-20 EP EP95928109A patent/EP0775160B1/en not_active Expired - Lifetime
- 1995-07-20 DE DE69533399T patent/DE69533399T2/de not_active Expired - Fee Related
- 1995-07-20 CA CA002195395A patent/CA2195395C/en not_active Expired - Fee Related
- 1995-07-20 BR BR9508467A patent/BR9508467A/pt not_active Application Discontinuation
- 1995-07-20 AU AU31984/95A patent/AU702917B2/en not_active Ceased
- 1995-07-20 US US08/776,160 patent/US5955426A/en not_active Expired - Fee Related
- 1995-07-20 CN CNB951949209A patent/CN1181096C/zh not_active Expired - Fee Related
- 1995-07-20 DK DK95928109T patent/DK0775160T3/da active
- 1995-07-20 AT AT95928109T patent/ATE273997T1/de not_active IP Right Cessation
- 1995-07-20 JP JP08506575A patent/JP3117218B2/ja not_active Expired - Fee Related
- 1995-07-20 KR KR1019970700606A patent/KR100322161B1/ko not_active IP Right Cessation
- 1995-07-27 ZA ZA956254A patent/ZA956254B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5955426A (en) | 1999-09-21 |
| US5932189A (en) | 1999-08-03 |
| CN1161698A (zh) | 1997-10-08 |
| ES2224131T3 (es) | 2005-03-01 |
| AU3198495A (en) | 1996-03-04 |
| JP3117218B2 (ja) | 2000-12-11 |
| KR100322161B1 (ko) | 2002-03-08 |
| EP0775160A1 (en) | 1997-05-28 |
| CA2195395A1 (en) | 1996-02-15 |
| BR9508467A (pt) | 1997-12-23 |
| EP0775160B1 (en) | 2004-08-18 |
| ZA956254B (en) | 1996-03-13 |
| AU702917B2 (en) | 1999-03-11 |
| DE69533399T2 (de) | 2005-09-01 |
| JPH10506880A (ja) | 1998-07-07 |
| ATE273997T1 (de) | 2004-09-15 |
| DE69533399D1 (en) | 2004-09-23 |
| CA2195395C (en) | 2001-05-01 |
| WO1996004308A1 (en) | 1996-02-15 |
| CN1181096C (zh) | 2004-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0775160T3 (da) | Cycliske hexapeptidsomatostatin-analoger | |
| DE69330521T2 (de) | Radioaktiv-markierte peptidderivate des somatostatin zur bildformenden und therapeutischen verwendung | |
| DK0614379T3 (da) | Technetium-99m-mærkede peptider til imagografi | |
| ATE199089T1 (de) | Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung | |
| ATE237637T1 (de) | Somatostatin derivate und deren radiomarkierte produkte | |
| NL194828B (nl) | Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten. | |
| EA199901025A1 (ru) | Пептидные аналоги паратиреоидного гормона | |
| CY1105763T1 (el) | Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους | |
| ES2076999T3 (es) | Peptidos anticoagulantes radiomarcados. | |
| NZ205241A (en) | Synthetic human (pre)prorelaxin; synthetic signal, a, b and c peptide chains thereof; preparation of human preprorelaxin, prorelaxin and relaxin by recombinant dna or other techniques | |
| HUP0000432A2 (hu) | Inzulin C-peptidek | |
| FI854383A (fi) | Foerfarande foer avspaltning av peptider och proteiner av metionyl-bindning. | |
| AP9100296A0 (en) | Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-1 and HTLV11 viruses. | |
| ITMI951670A0 (it) | Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita | |
| SE9402253D0 (sv) | Process | |
| CA2347670A1 (en) | Radiolabeled somatostatin-derived peptides for imaging |